Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01494844 · ClinicalTrials.gov registry record · Early Phase 1
Comfort Evaluation of Non-Invasive Respiratory Monitor Interfaces
A Early Phase 1 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT01494844 is a Early Phase 1 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants.
The verdict
NCT01494844, a Early Phase 1 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This research study will test the comfort of two noninvasive respiratory monitoring sensors (the connection to a monitor worn by a person-not the monitor). The two sensors, Masimo Rainbow Acoustic Monitoring sensor and Oridion Smart Capnoline Plus H sensor, are cleared by the U.S. Food and Drug Administration (FDA) and currently used in the clinical setting. People who enter into the study will wear the two interfaces, one after the other, for 20 minutes each (10 minutes with a small flow of air to the nostrils and 10 minutes without) and rate the comfort of each with a seven question survey. A total of 30 participants will be recruited.
Interventions
- DEVICE Respiratory monitor patient interface.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-06 |
| Est. Completion | 2011-09 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01494844
The ClinicalTrials.gov registry entry for NCT01494844 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Respiratory monitor patient interface. is the first listed.
NCT01494844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01494844 about?
NCT01494844 is a clinical study titled "Comfort Evaluation of Non-Invasive Respiratory Monitor Interfaces". This research study will test the comfort of two noninvasive respiratory monitoring sensors (the connection to a monitor worn by a person-not the monitor). The two sensors, Masimo Rainbow Acoustic Monitoring sensor and Oridion Smart Capnoline Plus H sensor, are cleared by the U.S. Food and Drug Admi...
What is the current status of trial NCT01494844?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2011-06. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01494844?
The interventions under investigation include: Respiratory monitor patient interface. (DEVICE).
Who is sponsoring clinical trial NCT01494844?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.